Marietta Investment Partners’s AbbVie ABBV Stock Holding History

Marietta Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.33M	Sell	33,693 -374	-1%	-$83K	1.47%	20
2025 Q4	$7.78M	Sell	34,067 -3,364	-9%	-$766K	1.55%	18
2025 Q3	$8.67M	Buy	37,431 +175	+0.5%	+$35.6K	1.67%	16
2025 Q2	$6.92M	Sell	37,256 -6,781	-15%	-$1.26M	1.51%	24
2025 Q1	$9.23M	Buy	44,037 +18,111	+70%	+$3.52M	2.22%	10
2024 Q4	$4.61M	Sell	25,926 -2	-0%	-$368	1.01%	30
2024 Q3	$5.12M	Hold	25,928	–	–	1.09%	29
2024 Q2	$4.45M	Sell	25,928 -65	-0.3%	-$10.8K	0.98%	34
2024 Q1	$4.73M	Hold	25,993	–	–	1.04%	34
2023 Q4	$4.03M	Sell	25,993 -800	-3%	-$117K	1%	35
2023 Q3	$3.99M	Hold	26,793	–	–	1.12%	28
2023 Q2	$3.61M	Hold	26,793	–	–	0.94%	32
2023 Q1	$4.27M	Buy	26,793 +600	+2%	+$91.7K	1.19%	28
2022 Q4	$4.23M	Hold	26,193	–	–	1.2%	29
2022 Q3	$3.81M	Buy	26,193 +180	+0.7%	+$25.8K	1.13%	28
2022 Q2	$3.98M	Sell	26,013 -1,480	-5%	-$226K	1.19%	30
2022 Q1	$4.46M	Hold	27,493	–	–	1.02%	32
2021 Q4	$3.72M	Hold	27,493	–	–	0.79%	40
2021 Q3	$2.97M	Hold	27,493	–	–	0.68%	44
2021 Q2	$3.1M	Sell	27,493 -220	-0.8%	-$24.8K	0.71%	42
2021 Q1	$3M	Hold	27,713	–	–	0.74%	42
2020 Q4	$2.97M	Sell	27,713 -560	-2%	-$53.8K	0.76%	39
2020 Q3	$2.48M	Sell	28,273 -60	-0.2%	-$5.65K	0.75%	33
2020 Q2	$2.78M	Hold	28,333	–	–	0.92%	34
2020 Q1	$2.16M	Hold	28,333	–	–	0.93%	30
2019 Q4	$2.51M	Buy	28,333 +1,700	+6%	+$141K	0.82%	34
2019 Q3	$2.02M	Sell	26,633 -200	-0.7%	-$13.7K	0.69%	33
2019 Q2	$1.95M	Sell	26,833 -5,650	-17%	-$444K	0.64%	42
2019 Q1	$2.62M	Sell	32,483 -362	-1%	-$29.6K	0.82%	42
2018 Q4	$3.03M	Buy	32,845 +2	+0%	+$176	1.16%	31
2018 Q3	$3.11M	Sell	32,843 -4,360	-12%	-$413K	0.92%	37
2018 Q2	$3.45M	Sell	37,203 -774	-2%	-$75.6K	1.07%	29
2018 Q1	$3.6M	Sell	37,977 -2,550	-6%	-$280K	1.08%	30
2017 Q4	$3.92M	Hold	40,527	–	–	1.11%	30
2017 Q3	$3.6M	Buy	40,527 +7,750	+24%	+$590K	1.08%	33
2017 Q2	$2.38M	Hold	32,777	–	–	0.76%	42
2017 Q1	$2.14M	Sell	32,777 -320	-1%	-$20.1K	0.71%	42
2016 Q4	$2.07M	Buy	33,097 +3,000	+10%	+$183K	0.73%	42
2016 Q3	$1.9M	Sell	30,097 -4,475	-13%	-$290K	0.62%	42
2016 Q2	$2.14M	Buy	34,572 +4,475	+15%	+$273K	0.76%	37
2016 Q1	$1.72M	Hold	30,097	–	–	0.71%	39
2015 Q4	$1.78M	Hold	30,097	–	–	0.72%	39
2015 Q3	$1.89M	Buy	30,097 +8,000	+36%	+$521K	0.74%	37
2015 Q2	$1.49M	Sell	22,097 -45	-0.2%	-$2.94K	0.58%	44
2015 Q1	$1.3M	Sell	22,142 -2,050	-8%	-$124K	0.51%	49
2014 Q4	$1.58M	Sell	24,192 -75	-0.3%	-$4.73K	0.64%	45
2014 Q3	$1.4M	Sell	24,267 -610	-2%	-$33.9K	0.62%	42
2014 Q2	$1.4M	Sell	24,877 -2,755	-10%	-$145K	0.58%	45
2014 Q1	$1.42M	Sell	27,632 -1,730	-6%	-$87.4K	0.55%	51
2013 Q4	$1.55M	Hold	29,362	–	–	0.56%	49
2013 Q3	$1.31M	Hold	29,362	–	–	0.52%	54
2013 Q2	$1.21M	Buy	+29,362	New	+$1.28M	0.52%	56

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marietta Investment Partners's ABBV Position: Q1 2026 in Review

Marietta Investment Partners reduced its AbbVie (ABBV) stake by 1.1% in Q1 2026, selling an estimated $83K and leaving 33,693 shares worth $7.33M. The position accounts for 1.47% of the portfolio, ranked #20.

Marietta Investment Partners first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.23M in Q1 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Marietta Investment Partners held 33,693 shares of AbbVie worth $7.33M as of Q1 2026.
Marietta Investment Partners sold 374 AbbVie shares in Q1 2026, an estimated $83K.
AbbVie made up 1.47% of Marietta Investment Partners's portfolio in Q1 2026, its #20 holding.
Marietta Investment Partners first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Marietta Investment Partners's AbbVie position peaked at $9.23M in Q1 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Marietta Investment Partners's 13F filing for Q1 2026, filed 28 Apr 2026.